I am extremely happy to share that our manuscript has been published in #Hypertension titled, "B-Cell Deficiency Lowers Blood Pressure in Mice". Please DM to receive the full-text: https://t.co/cvdSnm67iG. #immunology#bloodpressure#kidney#Bcells
@CircAHA#AHA21#HF Live forum happening now for: B-Cell-Mediated Sodium and Water Retention Contributes to Heart Failure Pathogenesis #P1964. Come say hello, connect, and leave any comments or questions!
Fantastic talks from Kenneth Walsh on the role of clonal hematopoiesis in heart failure, and from @CardioOncology on immune checkpoint inhibitor-associated cardiotoxicities at @KeystoneSymp#KSheartfail
Happy to share that my colleague, @DrAhsan6, from @mansoor_husain Lab, presented his recently published (Cardioprotective GLP-1 metabolite prevents ischemic cardiac injury by inhibiting mitochondrial trifunctional protein-α. https://t.co/EO3h8Jr2Nt) and new work at Keystone.
Excellent presentations from Lisa Mielniczuk on the role of metabolism in pulmonary hypertension and right HF, @mansoor_husain on GLP-1 [specifically, GLP-1 (28-36)] and SGLT2i in CVD and HF, and @FerhaanAhmad on SGLT1 in CVD and HF at @KeystoneSymp#KSheartfail
Fascinating first talk of Day-4, and the last day of @KeystoneSymp#KSheartfail, from @TravisHinson on a new functional assay to test the impact of heart failure-associated genetic variants.
Trainee Bliss Chang in the @rosenzweig_a lab @harvardmed sharing data on the interaction of age and exercise in the investigation of the mechanisms of heart failure. #KSexercise#KSheartfail
...and now Dr. Jane Reusch from @CUAnschutz is sharing her labs work on mechanisms of reduced exercise capacity in type 2 diabetes. #KSexercise#KSheartfail
Up now, Dr. Craig Emter from @Mizzou sharing data on the molecular mechanisms of interval training mediated improvements in cardiac function outcomes in a unique model of heart failure.
Dr. Anthony Rosenzweig (@rosenzweig_a) starts off the evening session @KeystoneSymp#KSheartfail#KSexercise, with data on using exercise-mediated cardiomyogenesis as a tool to investigate new targets in the treatment of heart failure.
The evening session is about to begin. Dr. Lisa Mielniczuk, from the University of Ottawa will chair the combined session, 'Exercise as a Treatment for Heart Failure.' @KeystoneSymp#KSexercise#KSheartfail
Stellar talks from Kory J. Lavine and
@SarahADick on the role of macrophage subsets in heart failure, @benoitbruneau on gene regulatory networks in heart development, and from Andy Yu on Activin-A in endothelial cell senescence and its potential role in HFpEF #KSheartfail
Very interesting and thought-provoking presentations on the pharmaceutical roadmap from Victor Shi, and on new mechanisms of cardiomyocyte proliferation from @HeshamS70605263 at @KeystoneSymp#KSheartfail!